These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3129103)

  • 1. Sulphonylureas and hypoglycaemia.
    Ferner RE; Neil HA
    Br Med J (Clin Res Ed); 1988 Apr; 296(6627):949-50. PubMed ID: 3129103
    [No Abstract]   [Full Text] [Related]  

  • 2. Factitious hypoglycaemia.
    Yates C; Neoh S; Konpa A; Fullinfaw R; Colman P
    Intern Med J; 2009 Dec; 39(12):e15-7. PubMed ID: 20233233
    [No Abstract]   [Full Text] [Related]  

  • 3. Octreotide treatment for sulfonylurea-induced hypoglycaemia.
    Crawford BA; Perera C
    Med J Aust; 2004 May; 180(10):540-1; author reply 541. PubMed ID: 15139835
    [No Abstract]   [Full Text] [Related]  

  • 4. Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis.
    Salvo F; Moore N; Arnaud M; Robinson P; Raschi E; De Ponti F; Bégaud B; Pariente A
    BMJ; 2016 May; 353():i2231. PubMed ID: 27142267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.
    Burge MR; Sood V; Sobhy TA; Rassam AG; Schade DS
    Diabetes Obes Metab; 1999 Jul; 1(4):199-206. PubMed ID: 11228754
    [No Abstract]   [Full Text] [Related]  

  • 6. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas.
    Stahl M; Berger W
    Diabet Med; 1999 Jul; 16(7):586-90. PubMed ID: 10445835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion of the EXAMINE study in a meta-analysis of the addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia.
    Boucaud-Maitre D
    BMJ; 2016 Jun; 353():i3186. PubMed ID: 27267596
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-acting sulfonylureas -- long-acting hypoglycaemia.
    Veitch PC; Clifton-Bligh RJ
    Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
    [No Abstract]   [Full Text] [Related]  

  • 9. Sulphonylurea-induced hypoglycaemia in institutionalized elderly in Hong Kong.
    So WY; Chan JC; Yeung VT; Chow CC; Ko GT; Li JK; Cockram CS
    Diabet Med; 2002 Nov; 19(11):966-8. PubMed ID: 12421437
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia.
    Graudins A; Linden CH; Ferm RP
    Am J Emerg Med; 1997 Jan; 15(1):95-6. PubMed ID: 9002583
    [No Abstract]   [Full Text] [Related]  

  • 11. Octreotide as antidote for sulfonylurea-induced hypoglycemia.
    Schier JG; Hirsch ON; Chu J
    Ann Emerg Med; 2001 Apr; 37(4):417-8. PubMed ID: 11275841
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adverse effects of sulfonylurea drugs].
    Kondo T; Yoshioka N; Koike T
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():178-81. PubMed ID: 18074535
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of factitious hypoglycaemia associated with sulphonylurea drugs in France in the year 2000.
    Trenque T; Frances C; Millart H; Hoizey G; Germain ML
    Br J Clin Pharmacol; 2002 Nov; 54(5):548. PubMed ID: 12445037
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients.
    Halimi S
    Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment: "Quantitative insulin and C peptide levels among ED patients with sulfonylurea-induced hypoglycemia".
    Livshits Z; Hoffman RS
    Am J Emerg Med; 2011 Sep; 29(7):812-3. PubMed ID: 21872103
    [No Abstract]   [Full Text] [Related]  

  • 16. Using pharmacoepidemiological findings to guide clinical practice: sulfonylureas and hypoglycemia in older adults.
    Gurwitz JH
    J Am Geriatr Soc; 1996 Jul; 44(7):871-2. PubMed ID: 8675941
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative tolerability of sulphonylureas in diabetes mellitus.
    Harrower AD
    Drug Saf; 2000 Apr; 22(4):313-20. PubMed ID: 10789825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphonylurea hypoglycaemic agents.
    Kermode AG; McNally KM; Joyce DA
    Med J Aust; 1992 Nov; 157(10):717, 720. PubMed ID: 1435430
    [No Abstract]   [Full Text] [Related]  

  • 19. [Toxic hypoglycemia].
    Dorf G; Tutin M; Bour H
    Diabete; 1972; 20(2):121-31. PubMed ID: 5086121
    [No Abstract]   [Full Text] [Related]  

  • 20. Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening.
    Earle KE; Rushakoff RJ; Goldfine ID
    Diabetes Technol Ther; 2003; 5(3):449-51. PubMed ID: 12828829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.